Analyst Ranking
Bottom 2%
#4886 out of 4981 analysts
Average Return
-10.68%
Win Rate
32%37 out of 117
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+366.27%$0.83$3.87
2024-08-14 -
2025-08-13
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-05 -
2021-02-05
Buy
Lantheus Holdings IncLNTH
+67.88%$64.32$107.98
2023-11-03 -
2024-11-01
Buy
Paragon 28 IncFNA
+58.67%$8.25$13.09
2024-05-09 -
2025-04-17
Buy
Si Bone IncSIBN
+34.91%$12.69$17.12
2022-11-08 -
2023-11-07
Buy

David Turkaly Analyst Color

Get additional color on David Turkaly's coverage of popular stocks

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Orthopediatrics CorpKIDS
11Buy$35.00+82.39%Maintains
10 days ago
Lantheus Holdings IncLNTH
9Buy$73.00+34.74%Maintains
11 days ago
Haemonetics CorpHAE
9Buy$100.00+86.08%Reiterates
3 months ago
Steris PLCSTE
15Buy$280.00+14.03%Maintains
3 months ago
Integra Lifesciences Holdings CorpIART
13Buy$25.00+76.18%Maintains
3 months ago
Enovis CorpENOV
2Buy$55.00+86.13%Maintains
3 months ago
Zimmer Biomet Holdings IncZBH
11Buy$125.00+21.65%Maintains
3 months ago
Crowdstrike Holdings IncCRWD
1Buy$500.00+16.85%Maintains
3 months ago
Tela Bio IncTELA
6Buy$7.00+343.04%Maintains
5 months ago
Axogen IncAXGN
5Buy$26.00+74.15%Reiterates
5 months ago
Si Bone IncSIBN
6Buy$32.00+106.99%Reiterates
6 months ago
Snap IncSNAP
1Buy$16.00+123.78%Reiterates
7 months ago
Neuronetics IncSTIM
4Buy$3.00N/AMaintains
a year ago
Paragon 28 IncFNA
4Buy$20.00N/AMaintains
a year ago
Teleflex IncTFX
10Buy$285.00N/AReiterates
a year ago
Nevro CorpNVRO
5Buy$40.00N/AMaintains
2 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
2 years ago
Apyx Medical CorpAPYX
1Buy$14.00N/AMaintains
4 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.